Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill.
Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri3Goryeb Children's Hospital, Atlantic Health System, Morristown, New Jersey.
JAMA Pediatr. 2016 May 2;170(5):e154577. doi: 10.1001/jamapediatrics.2015.4577.
Human lung growth and development begins with preconception exposures and continues through conception and childhood into early adulthood. Numerous environmental exposures (both positive and negative) can affect lung health and disease throughout life. Infant lung health correlates with adult lung function, but significant knowledge gaps exist regarding the influence of preconception, perinatal, and postnatal exposures on general lung health throughout life. On October 1 and 2, 2015, the National Heart, Lung, and Blood Institute convened a group of extramural investigators to develop their recommendations for the direction(s) for future research in prenatal and perinatal determinants of lung health and disease in early life and to identify opportunities for scientific advancement. They identified that future investigations will need not only to examine abnormal lung development, but also to use developing technology and resources to better define normal and/or enhanced lung health. Birth cohort studies offer key opportunities to capture the important influence of preconception and obstetric risk factors on lung health, development, and disease. These studies should include well-characterized obstetrical data and comprehensive plans for prospective follow-up. The importance of continued basic science, translational, and animal studies for providing mechanisms to explain causality using new methods cannot be overemphasized. Multidisciplinary approaches involving obstetricians, neonatologists, pediatric and adult pulmonologists, and basic scientists should be encouraged to design and conduct comprehensive and impactful research on the early stages of normal and abnormal human lung growth that influence adult outcome.
人类肺部的生长和发育始于受孕前的暴露,并贯穿受孕、儿童期直至成年早期。许多环境暴露(包括正面和负面的)都会影响整个生命周期的肺部健康和疾病。婴儿期的肺部健康与成人的肺功能相关,但对于受孕前、围产期和产后暴露对整个生命周期的肺部健康的影响,仍存在显著的知识空白。
2015 年 10 月 1 日和 2 日,美国国立心肺血液研究所召集了一批校外研究人员,为未来关于产前和围产期决定生命早期肺部健康和疾病的研究方向提出建议,并确定了科学进步的机会。他们认为,未来的研究不仅需要检查异常的肺部发育,还需要利用不断发展的技术和资源,更好地定义正常和/或增强的肺部健康。
出生队列研究为捕捉受孕前和产科风险因素对肺部健康、发育和疾病的重要影响提供了关键机会。这些研究应包括特征明确的产科数据和前瞻性随访的综合计划。强调继续进行基础科学、转化和动物研究以利用新方法提供解释因果关系的机制至关重要。应鼓励多学科方法,包括产科医生、新生儿科医生、儿科和成人肺科医生以及基础科学家,以设计和进行关于正常和异常人类肺部生长的早期阶段的全面和有影响力的研究,这些研究将影响成人的结果。